International Nonproprietary Name , INN (Abkürzung)

'Ciprofloxacin' (International Nonproprietary Name) is a drug used to treat bacterial infections.

'Gemfibrozil' is the International Nonproprietary Name for an oral drug used to lower lipid levels.

Pseudoephedrine is the International Nonproprietary Name of the (+)-form, when used as pharmaceutical substance.

With the International Nonproprietary Name amifampridine, it is used as a drug, predominantly in the treatment of a number of rare muscle diseases.

The International Nonproprietary Name "retigabine" was initially published as being under consideration by WHO in 1996.

International Nonproprietary Name (INN)

The International Nonproprietary Name (INN) of methylene blue is methylthioninium chloride.

Macrogol is the International Nonproprietary Name (INN) for polyethylene glycol.

Its British Approved Name was danthron, but it has now been changed to "dantron", the recommended International Nonproprietary Name.

The list uses the International Nonproprietary Name (INN) of the drugs but in some cases mentions drugs by their chemical name.

Where a compound has a WHO International Nonproprietary Name (INN), this should be used as the article title.

In July 2009, Pfizer and Medivation announced that "latrepirdine" will be the proposed international nonproprietary name for latrepirdine for the treatment of Alzheimer's.

Internationally, generic names, known as the International Nonproprietary Name, are issued by the World Health Organization (WHO) in several languages, including English.

The active ingredient of its original flagship product is acetaminophen, an analgesic and antipyretic; it is commonly known elsewhere in the world by its international nonproprietary name, paracetamol.

The International Nonproprietary Names of humanized antibodies end in -zumab, as in omalizumab (see Nomenclature of monoclonal antibodies).

'Metronidazole' (International Nonproprietary Name) () is a nitroimidazole antibiotic medication used mainly in the treatment of infections caused by susceptible organisms, particularly anaerobe bacterium and protozoa.

The World Health Organization (WHO) introduced the system of International Nonproprietary Names in 1950, with the first INN list being published three years later.

This chemical is widely referred to as "adrenaline" outside the United States; however, its United States Adopted Name and International Nonproprietary Name is epinephrine.

'Methotrexate' (International Nonproprietary Name) (), abbreviated 'MTX' and formerly known as 'amethopterin', is an antimetabolite and antifolate drug used in treatment of cancer and autoimmune diseases.

The modified antibody accumulates in the tumour cells, concentrating the effects of the radioactivity of Y. Drugs containing this module receive an International Nonproprietary Name ending in tetraxetan:

Drugs, in the majority of circumstances, have 3 names: the chemical name, the International Nonproprietary Name (INN, also known as the generic or nonproprietary name), and the brand name.

When modifying the International Nonproprietary Name of a pharmaceutical substance containing the group or anion, the correct spelling is mesilate (as in imatinib mesilate, the mesylate salt of imatinib).

This naming scheme is used for both the World Health Organization's International Nonproprietary Names (INN) and the United States Adopted Names (USAN) for pharmaceuticals.

Pharmaceuticals in the CPS are listed by their brand name, as opposed to by the International Nonproprietary Name (INN) or United States Adopted Name (USAN).

The name picaridin was proposed as an International Nonproprietary Name (INN) to the World Health Organization (WHO), but the official name that has been approved by the WHO is icaridin.